Sort
35,931 grants matching “parkinsons”
Anterior Striatum and Visual Motor Learning
$419,958Emad N Eskandar · Massachusetts General Hospital · R01 · FY2011 · EY
Project 1: Role of Innate Immune Cells in Human Parkinson Disease
$419,913David G Standaert · University Of Alabama At Birmingham · P50 · FY2021 · NS
Project 1: Role of Innate Immune Cells in Human Parkinson Disease
$419,913David G Standaert · University Of Alabama At Birmingham · P50 · FY2022 · NS
Scalable, all-optical assays of synaptic function and plasticity
$419,790Graham Thomas Dempsey · Q-State Biosciences, Inc. · R43 · FY2017 · MH
Hsp90 Dependent Rab Tethering
$419,789William Edward Balch · Scripps Research Institute, The · R01 · FY2009 · GM
Pharmacology of Dopamine Release by Amphetamine
$419,770Margaret E Gnegy · University Of Michigan At Ann Arbor · R01 · FY2014 · DA
CORE--CLININCAL
$419,760University Of California Los Angeles · P50 · FY2005 · AG
Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials
$419,729Dennis Alan Turner · Duke University · UH3 · FY2021 · NS
Mechanistic Studies on video guided acupuncture imagery treatment of pain
$419,641Jian Kong · Massachusetts General Hospital · R61 · FY2017 · AT
The first adaptable, 3D-formfitting microelectrode array for organoid-based models of neurological and neurodegenerative diseases
$419,641Oliver Graudejus · Bmseed, Llc · R43 · FY2021 · NS
Fbw7 as a therapeutic target for treating Parkinson's disease
$419,563Steven I Reed · Scripps Research Institute, The · R01 · FY2016 · NS
Ethics of Control and Consent in Brain Stimulation for Parkinson Disease
$419,534Paul Jason Ford · Cleveland Clinic Lerner Com-Cwru · RC1 · FY2010 · NS
Assessment of Candidate Loci in Neurological diseases
$419,527Andrew Singleton · National Institute On Aging · ZIA · FY2015 · AG
Scalable Assays for Morphological Analysis of Mammalian Neurons
$419,513Bernardo L Sabatini · Harvard Medical School · R01 · FY2014 · NS
Systematic discovery and functional analysis of the PARKIN modified proteome
$419,513Jeffrey Wade Harper · Harvard Medical School · R37 · FY2014 · NS
Elucidation of the structures and biological activities of huntingtin oligomers
$419,472Paul J Muchowski · J. David Gladstone Institutes · R01 · FY2007 · NS
Elucidation of the structures and biological activities of huntingtin oligomers
$419,472Paul J Muchowski · J. David Gladstone Institutes · R01 · FY2009 · NS
Elucidation of the structures and biological activities of huntingtin oligomers
$419,472Paul J Muchowski · J. David Gladstone Institutes · R01 · FY2008 · NS
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands
$419,469Kwang-Soo Kim · Mclean Hospital · R01 · FY2024 · NS
Neuroplasticity in chemosensory-mediated social behaviors
$419,457Hua Yan · University Of Florida · R01 · FY2025 · DC
Neuroplasticity in chemosensory-mediated social behaviors
$419,457Hua Yan · University Of Florida · R01 · FY2024 · DC
Akt/GSK-3 Signaling Cascade and the Actions of Dopamine
$419,434Duke University · R01 · FY2005 · MH
The Norepinephrine transporter as a therapeutic target for treatment of alpha-synuclein pathology in PD
$419,375Nikhil Urs · University Of Florida · R21 · FY2021 · NS
Immunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy?
$419,375Vinata Vedam-Mai · University Of Florida · R21 · FY2023 · NS
Ribosome-Associated Regulation of Yeast Prion Formation
$419,373Dale Cameron · Ursinus College · R15 · FY2019 · GM